Skip over navigation
The Hospital
Research
Support Us
Ottawa Hospital Research Institute
Home
Français
Directions & Maps
Contact Us
About Us
Vision and Strategic Directions
Board Chair and CEO Message
Leadership Team
Annual Reports
Facilities
Research Data Management
Equity, Diversity and Inclusion
Wellness
Our Research
Priorities, Programs and Diseases
Researcher Profiles
National Research Networks
Scientific Publications
Research Awards
Technology Transfer
Industry Sponsored Research
Responsible Innovation
For Students & Fellows
News & Events
Newsroom
Seminars & Events
Career Opportunities
For Patients
News & Events
Home
>
News & Events
>
Newsroom
Bookmark or Share
Display Options
Display Options
+
Increase
/
-
Decrease
font size
High contrast version
Printer-friendly version
Newsroom
Seminars & Events
Newsroom
Study reveals novel approach to stop cancer cells from dividing
November 28, 2011
While the goal of most cancer treatments is to kill cancer cells, new research led by
Dr. Ian Lorimer
suggests that preventing cancer cells from dividing may also be a valuable strategy. In a paper published in
Oncogene
, Dr. Lorimer and his team show that blocking a protein called PKCiota in breast and brain cancer cells causes them to stop dividing and become permanently “senescent”. This same strategy had no effect on normal cells. While this research is still in the early stages, it represents an important new avenue to explore for future cancer treatment approaches.
This research was supported by the Canadian Institutes of Health Research, the Ottawa Regional Cancer Foundation and the Ontario Ministry of Economic Development and Innovation.